You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis E

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Trial in Worldwide (GSK3228836, PegIFN, NA therapy)

Active, not recruiting
  • Hepatitis B
  • Sacramento, California
  • +48 more
Jan 19, 2023

Hepatitis E Virus Infection Trial

Completed
  • Hepatitis E Virus Infection
    • (no location specified)
    Sep 13, 2020

    Chronic HBV Infection Trial in Hong Kong, Taiwan (EDP-514, Placebo)

    Completed
    • Chronic HBV Infection
    • Hong Kong, Hong Kong
    • +9 more
    Jan 6, 2022

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

    Recruiting
    • Hepatitis B, Chronic
    • Vancouver, British Columbia, Canada
    • +31 more
    Jan 17, 2023

    Hepatitis B, Chronic Trial in Worldwide (VIR-2218, VIR-3434, PEG-IFNa)

    Recruiting
    • Hepatitis B, Chronic
    • San Francisco, California
    • +39 more
    Oct 3, 2022

    Hepatitis D, Chronic Trial in Worldwide (JNJ-73763989, Placebo, Entecavir (ETV) monohydrate)

    Active, not recruiting
    • Hepatitis D, Chronic
    • Redwood City, California
    • +68 more
    Jan 17, 2023

    HBV, Chronic HBV Infections Trial in China (TAF, TDF, TAF Placebo)

    Active, not recruiting
    Has Results
    • HBV
    • Chronic HBV Infections
    • Beijing, China
    • +24 more
    Mar 17, 2022

    Hepatitis E Trial in Dongtai (hepatitis E vaccine, Hepatitis B vaccine)

    Completed
    • Hepatitis E
    • hepatitis E vaccine
    • Hepatitis B vaccine
    • Dongtai, Jiangsu, China
      Dongtai Center for Disease Control and Prevention
    Jul 9, 2020

    Hepatitis B, Chronic Trial in Worldwide (Tenofovir Alafenamide)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Tenofovir Alafenamide
    • Palo Alto, California
    • +11 more
    Dec 1, 2021

    Chronic Hepatitis B Virus Trial in San Francisco (Stop NA therapy)

    Active, not recruiting
    • Chronic Hepatitis B Virus
    • Stop NA therapy
    • San Francisco, California
    • +1 more
    Mar 29, 2021

    Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir

    Terminated
    • Hepatitis C Virus Infection
    • Sofosbuvir (SOF)
    • +3 more
    • Phoenix, Arizona
    • +50 more
    Jan 25, 2023

    Chronic Hepatitis b, Hepatitis B Reactivation Trial in Taiwan (Vemlidy)

    Recruiting
    • Chronic Hepatitis b
    • Hepatitis B Reactivation
    • Chiayi City, Taiwan
    • +6 more
    Aug 4, 2021

    Predictive Model for Prognosis of Chronic HBV Infection Mothers

    Recruiting
    • Hepatitis B, Chronic
    • Age, BMI,Baseline HBV DNA, Baseline HBeAg level, Baseline HBsAg level, Antiviral treatment, Serum ALT level
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Aug 20, 2021

    Hepatitis E Trial in Dongtai (Participants would receive 3 doses of Recombinant Hepatitis E Vaccine (Escherichia Coli)

    Completed
    • Hepatitis E
    • Participants would receive 3 doses of Recombinant Hepatitis E Vaccine (Escherichia Coli) intramuscularly at 0, 1, 6 month.
    • Dongtai, Jiangsu, China
      Dongtai City Center for Disease Control and Prevention
    May 6, 2020

    Chronic Hepatitis b Trial in Daegu, Seoul, Ulsan (Tenofovir Alafenamide)

    Recruiting
    • Chronic Hepatitis b
    • Tenofovir Alafenamide
    • Daegu, Korea, Republic of
    • +9 more
    Dec 20, 2021

    Large-B-cell Diffuse Lymphoma, Chronic Lymphoid Leukemia Trial in Italy (Rituximab, Chemotherapy, Tenofovir alafenamide)

    Recruiting
    • Large-B-cell Diffuse Lymphoma
    • Chronic Lymphoid Leukemia
    • Roma, (rm), Italy
    • +30 more
    Jan 3, 2022

    Hepatitis B Trial in Korea, Republic of, Taiwan, United Kingdom (ChAdOx1-HBV, MVA-HBV, Nivolumab)

    Recruiting
    • Hepatitis B
    • ChAdOx1-HBV
    • +2 more
    • Busan, Korea, Republic of
    • +13 more
    Mar 29, 2022

    Seroprevalence Hepatitis E Infection in Healthy Blood Donors

    Completed
    • Hepatitis E
    • Sample collection
    • Lugano,, Switzerland
      Swiss Transfusion SRC Canton Ticino
    Mar 30, 2020

    Hepatitis B Trial in Worldwide (JNJ-56136379, Placebo, NA (ETV or TDF))

    Completed
    Has Results
    • Hepatitis B
    • Bakersfield, California
    • +75 more
    Oct 24, 2022

    Hepatitis B, Chronic Trial in Worldwide (ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation,

    Recruiting
    • Hepatitis B, Chronic
    • ChAd155-hIi-HBV low dose formulation
    • +6 more
    • Antwerpen, Belgium
    • +35 more
    Jan 28, 2022

    Chronic Hepatitis B Trial in Worldwide (TAF, Placebo)

    Recruiting
    • Chronic Hepatitis B
    • Los Angeles, California
    • +58 more
    Jul 14, 2022

    Alcoholic Hepatitis Trial in Worldwide (DUR-928 30 mg, DUR-928 90 mg, Placebo+ Standard of Care (SOC))

    Recruiting
    • Alcoholic Hepatitis
    • DUR-928 30 mg
    • +2 more
    • Birmingham, Alabama
    • +68 more
    Nov 7, 2022

    Hepatitis C, Chronic, Opioid-Related Disorders Trial in Germany

    Completed
    • Hepatitis C, Chronic
    • Opioid-Related Disorders
      • Munich, Bavaria, Germany
      • +17 more
      Apr 27, 2021

      Hepatitis B Trial in Worldwide (GSK3228836, Placebo, Nucleos(t)ide therapy)

      Completed
      • Hepatitis B
      • Los Angeles, California
      • +120 more
      Jul 1, 2022

      Hepatitis C Infection Trial in United States (MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2))

      Terminated
      Has Results
      • Hepatitis C Infection
      • MBL-HCV1
      • +2 more
      • Boston, Massachusetts
      • +4 more
      Feb 4, 2021